Page 2 - Quarterly Summary News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quarterly summary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quarterly Summary Today - Breaking & Trending Today

States Made More Than $5.7 Billion In Marijuana Tax Revenue Over 18-Month Period, New Federal Census Bureau Report Shows

The U.S. Census Bureau has released its first report on state-level marijuana tax revenue data following what the agency calls “a complete canvass of all state agencies” going back to July 2021. In the 18-month period between then and the end of 2022, the data show, states collected more than $5.7 billion from licensed cannabis […] ....

United States , New Mexico , Rhode Island , New York , Kaliko Castille , David Culver , Aaaron Smith , Minority Cannabis Business Association , Office Of Cannabis Policy , National Cannabis Industry Association , Census Bureau , Us Cannabis Council , Us Census Bureau , Quarterly Summary , Local Government Tax Revenue , President Biden , Cannabis Policy ,

Glaukos Announces Second Quarter 2023 Financial Results

ALISO VIEJO, Calif. (BUSINESS WIRE) Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the second quarter ended June 30, 2023. Key highl. ....

Thomas Burns , Chris Lewis , Exchange Commission , Investor Relations Corporate Affairs , Corneal Health , Avedro Inc , Glaukos Corporation , International Glaucoma , Investor Relations , Quarterly Summary , Micro Invasive Glaucoma Surgery , Quarterly Report , Investor Section , Regarding Use , Generally Accepted Accounting Principles , Corporate Affairs ,

Glaukos Announces First Quarter 2023 Financial Results

ALISO VIEJO, Calif. (BUSINESS WIRE) Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2023. Key highl. ....

Thomas Burns , Chris Lewis , International Glaucoma , Investor Relations Corporate Affairs , Avedro Inc , Ivantis Inc , Exchange Commission , Corneal Health , Glaukos Corporation , Investor Relations , Quarterly Summary , Micro Invasive Glaucoma Surgery , Annual Report , Quarterly Report , Investor Section , Regarding Use , Generally Accepted Accounting Principles , Corporate Affairs ,